Article

bangordailynews.com on 2021-06-07 20:40

FDA approves much-debated Alzheimer’s drug panned by experts

It's the only drug that U.S. regulators have said can likely treat the underlying disease, rather than manage symptoms like anxiety and insomnia.

Related news